Drug
Tenofovir DF
Tenofovir DF: highest development phase Post-Market, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tenofovir DF NCT02479880 | Post-Market | Hepatitis B |
Latest
No recent events.
Follow Tenofovir DF on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.